Dailypharm Live Search Close

MSD¡¯s Keytruda becomes the 'symbol' of cancer immunotherapy

By Eo, Yun-Ho | translator Alice Kang

21.08.24 17:18:11

°¡³ª´Ù¶ó 0
Keytruda secures 18 indications in 14 cancer types... 120 studies are being conducted that involves Korea

Rises as the No.1 global anticancer drug¡¦whether its reimbursement will be extended to the indications remain an issue



 ¡ãPic. of Keytruda


¡°Reinforcing the body¡¯s immunity to attack cancer cells¡±

By some, the idea was regarded improbable. Not many were convinced that immunotherapy would rise to the position it is in now. Even without reference to the famous story of how the former US president Jimmy Carter cured melanoma with immunotherapy, cancer immunotherapy has become an important pillar in the management of cancer disease nowadays.

Among the many drugs introduced, MSD¡¯s (Merck in the US) ¡®Keytruda (pembrolizumab)¡¯ has risen to become the symbol of ¡®cancer immunotherapy.¡¯ The drug, which was first approved in March 2015 as a treatment for melanoma, is currently approved for 18 indications in 1

Eo, Yun-Ho(unkindfish@dailypharm.com)
If you want to see the full article, please JOIN US (click)